IMPROVING DOOR TO BALLOON TIME IN PATIENTS WITH STEMI IN THE EMERGENCY DEPARTMENT BY IMPLEMENTING CLINICAL CODE "CARDIAC ALERT"

Dr Rupesh Purushottam Bokade, Dr Kayanoosh Kadapatti, Dr Sayed Fiyaz Pasha

Abstract


INTRODUCTION: Over the past 25 years, the survival of patients with ST-segment elevation myocardial infarction (STEMI) has improved
substantially, with the development of thrombolytic therapy, primary percutaneous coronary intervention (PCI), and improvements in adjunctive
medical therapy. During the past decade, primary PCI has become the preferred treatment strategy when experienced operators and hospitals are
available within an appropriate time frame.For both primary PCI and thrombolytic therapy, analyses have consistently shown that timeliness of
reperfusion is a major prognostic factor in improving patient survival. For PCI, the American College of Cardiology has recommended a delay of
no more than 90 minutes from initial hospital contact to first balloon inflation.
METHODS: CARDIAC ALERT code was implemented and included activation of cardiac catheterization laboratory by emergency medicine
physician. We retrospectively reviewed 190 patients with a diagnosis of STEMI, a period of time before and after implementation of a clinical code
aimed at reducing door to balloon time.
RESULTS: Door to balloon time was compared between groups before (n=95),and after (n=95)clinical code implementation. Median door to
balloon time for the former group was 129.73 minutes and for the latter group 70 minutes. Prior to implementation of protocol a door to balloon
time of <90 minutes was achieved in 15.6% of cases.By the end of study, this goal was being met in 90.5%.
CONCLUSION: This observational study provides support for the use of Clinical Code CARDIAC ALERT as a key for reduction in door to
balloon time. Our experience demonstrates extensive interdisciplinary collaboration and explicit strategies for overcoming the barriers to
organizational change.


Keywords


Stemi, Code Cardiac Alert, Emergency Medicine, Door To Balloon Time

Full Text:

PDF

References


Organisation Mondiale de la santé. Global status report on noncommunicable diseases 2014: attaining the nine global noncommunicable diseases targets; a shared responsibility. Geneva: World Health Organization; 2014.

Gupta R, Misra A, Pais P, Rastogi P, Gupta VP. Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factors. Int J Cardiol. 2006 Apr 14;108(3):291–300.

Xavier D, Pais P, Devereaux P, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. The Lancet. 2008 Apr;371(9622):1435–42.

Shah B, Mathur P. Surveillance of cardiovascular disease risk factors in India: The need & scope. Indian J Med Res. 2010 Nov;132(5):634–42.

Berger P, Ellis S, Holmes D, Granger C, Criger D, Betriu A et al. Relationship Between Delay in Performing Direct Coronary Angioplasty and Early Clinical Outcome in Patients With Acute Myocardial Infarction : Results From the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial. Circulation. 1999;100(1):14-20.

McNamara RL, Wang Y, Herrin J, Curtis JP, Bradley EH, Magid DJ et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology. 2006 Jun 6;47(11):21806..

Steg PG, James SK, Gersh BJ. 2012 ESC STEMI guidelines and reperfusion therapy: Evidence-based recommendations, ensuring optimal patient management. Heart.2013;99(16):1156-1157.

Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet. 2006;367(9510):579-588.

Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycien K, Jodko L, Skowronek A, Kurowski M, et al. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy. Kardiol Pol. 2006;64(6):591-599; discussion 600-591.

Brodie BR, Hansen C, Stuckey TD, Richter S, Versteeg DS, Gupta N, Downey WE, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol. 2006;47(2):289-295.

Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, et al. Relationship of symptomonset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000;283(22):2941-2947.

Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, AskariAT, Peacock WF, Peterson ED, et al. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009;302(20):2207-2213.

Bradley EH, Nallamothu BK, Herrin J, Ting HH, Stern AF, Nembhard IM, Yuan CT, et al. National efforts to improve door-to-balloon time results from the Door-to- Balloon Alliance. J Am Coll Cardiol. 2009;54(25):2423-2429.

Lassen JF, Botker HE, Terkelsen CJ. Timely and optimal treatment of patients with STEMI. Nat Rev Cardiol. 2013;10(1):41-48.


Refbacks

  • There are currently no refbacks.